Temporal Trends in the Use of Anticoagulants Among Older Adults With Atrial Fibrillation
Open Access
- 26 July 1999
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 159 (14) , 1574-1578
- https://doi.org/10.1001/archinte.159.14.1574
Abstract
COMPARED WITH placebo, warfarin sodium treatment dramatically reduces the risk of stroke, systemic embolisms, and death in persons with atrial fibrillation.1-5 The benefits of aspirin treatment—with or without fixed-dose warfarin—are less pronounced than those of adjusted-dose warfarin6,7 but are nonetheless significant.1,3,8This publication has 2 references indexed in Scilit: